Scc skin cancer
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Cutaneous Squamous Cell Carcinoma (SCC): Insights and Advances
Epidemiology and Risk Factors of SCC
Cutaneous squamous cell carcinoma (SCC) is one of the most common skin cancers, particularly prevalent among white populations. It is more frequently diagnosed in men than women and its incidence increases significantly with age. The primary external risk factor for SCC is solar ultraviolet radiation (UVR), with immunosuppression also playing a significant role, as evidenced by the high rates of SCC in organ transplant recipients. Other associated risk factors include sunbed use, certain genetic disorders, and medical conditions, although the links to human papillomavirus infection and high body weight are not well established. Actinic keratoses (AKs), which are precancerous lesions caused by sun damage, are strong predictors of SCC development.
Genetic Susceptibility and Molecular Insights
Recent genome-wide meta-analyses have identified several genetic loci associated with SCC susceptibility. A study involving 19,149 SCC cases and 680,049 controls discovered eight novel loci and confirmed previously identified ones. These loci are involved in cancer development, immune regulation, and keratinocyte differentiation, highlighting the complex genetic underpinnings of SCC. Additionally, research using mouse models has shown that different epidermal lineages, including hair follicle bulge stem cells, can initiate squamous tumor formation when specific genetic mutations, such as KRas activation and p53 loss, are present.
Treatment Modalities for SCC
The primary treatment for non-metastatic SCC is surgical excision, which can be performed using various techniques such as Mohs micrographic surgery, which offers high cure rates while preserving healthy tissue . Other treatment options include cryotherapy, electrodessication and curettage, radiation therapy, photodynamic therapy, and topical medications . For advanced SCC (aSCC), which is not amenable to surgery or radiotherapy, immunotherapy has emerged as a promising treatment. Drugs like cemiplimab and pembrolizumab, which target immune checkpoint molecules such as PD-1, have shown efficacy, although the response rate remains around 50% .
The Role of the Tumor Microenvironment
The tumor microenvironment (TME) plays a crucial role in SCC progression and response to treatment. Chronic inflammation, often driven by factors such as Staphylococcus aureus infections, can promote SCC development by inducing pro-inflammatory responses in the skin. Understanding the interactions within the TME, including the role of immune checkpoint molecules, is essential for developing more effective therapeutic strategies.
Prevention and Public Health Strategies
Preventing SCC primarily involves protecting the skin from excessive UVR exposure. This can be achieved through the use of sunscreen, protective clothing, and behavioral interventions aimed at reducing sun exposure, especially in high-risk groups such as outdoor workers and children. Public health policies, such as restricting the tanning industry, can also play a significant role in reducing SCC incidence.
Conclusion
Cutaneous squamous cell carcinoma is a prevalent and potentially serious skin cancer with a complex interplay of genetic, environmental, and immunological factors. Advances in genetic research, treatment modalities, and understanding of the tumor microenvironment are paving the way for more effective management and prevention strategies. Continued research and public health initiatives are essential to control the growing burden of SCC.
Sources and full results
Most relevant research papers on this topic